Nordic Nanovector: Second Quarter Report 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Please find enclosed the report for the second quarter 2014.

Highlights for second quarter 2014:

• The lead product candidate Betalutin™ has been granted orphan drug designation for treatment of follicular lymphoma in Europe and in the USA.

Help employers find you! Check out all the jobs and post your resume.

Back to news